Page - (000224) - in Biomedical Chemistry: Current Trends and Developments
Image of the Page - (000224) -
Text of the Page - (000224) -
promoiety dependency. Thus, the permeability of the 5β-L-valyl prodrug
was roughly 2- and 5-fold higher than the permeability of 5β-L-isoleucyl
and 5β-leucyl floxuridine prodrugs, respectively (Landowski, 2005a).
The metabolic conversion of floxuridine to 5-fluorouacil (5-FU)
following systemic delivery has been shown to be detrimental to the
therapeutic efficacy of floxuridine. The mechanism of action of these
two drugs are well understood, where the toxicity of 5-FU is
predominantly caused by 5-FU incorporation into RNA. Unlike 5-FU,
floxuridine is specifically incorporated into DNA, which leads to the
minimization of adverse effects. It is important to highlight that
floxuridine has shown to inhibit cell proliferation 10- to 100-fold more
than 5-FU. However, floxuridine is rapidly converted to 5-FU in many
tissues (including the liver) by the enzyme thymidine phosphorylase
(Tsume, 2008). As a consequence, higher doses of floxuridine are
required to maintain clinical efficacy, which leads to greater toxicity.
Therefore, protection of floxuridine prodrugs against this enzyme is
essential to enhance therapeutic efficacy at low doses and obviate
toxicity.
All amino acid ester prodrugs examined by Landowski and co-
workers were stable to glycosidic bond cleavage by thymidine
phosphorylase. It is therefore possible to conclude that modification of
one or both of the free hydroxyl groups on the sugar moiety provide
protection from glycosidic bond cleavages. The rate of conversion of the
prodrugs to the parent drug after transport would determine floxuridine
disposition and therapeutic action (Landowski, 2005a). As previously
reported to structure, stereochemistry and the site of esterification of the
amino acid promoiety affect the rates of activation of floxuridine
prodrugs. Therefore, the wide range of variations for prodrug structure
suggests that the hydrolysis rate can be tailored to produce a prodrug
with the desired half-life (Landowski, 2005a; Vig, 2003).
The roughly 5- to 12-fold higher activity in Caco-2 cell homogenates
compared with pH 7.4 buffer suggests the predominance of enzymatic
bioconversion of the prodrugs. The results obtained for the leucyl ester
prodrugs indicate that they would not be suitable candidates. In
comparison, isoleucyl ester prodrugs of floxuridine are enzymatically
Biomedical Chemistry: Current Trends and Developments
- Title
- Biomedical Chemistry: Current Trends and Developments
- Author
- Nuno Vale
- Publisher
- De Gruyter Open Ltd
- Date
- 2016
- Language
- English
- License
- CC BY-NC-ND 4.0
- ISBN
- 978-3-11-046887-8
- Size
- 21.0 x 29.7 cm
- Pages
- 427
- Keywords
- Physical Sciences, Engineering and Technology, Chemistry, Organic Chemistry, Green Chemistry
- Categories
- Naturwissenschaften Chemie